UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes Journal article
Wang, Kewei, Li, Zixi, Xuan, Ying, Zhao, Yong, Deng, Chao, Wang, Meidan, Xie, Chenjun, Yuan, Fenglai, Pang, Qingfeng, Mao, Wenjun, Cai, Dongyan, Zhong, Zhangfeng, Mei, Jie. Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes[J]. Cancer Cell International, 2023, 23(1), 229.
Authors:  Wang, Kewei;  Li, Zixi;  Xuan, Ying;  Zhao, Yong;  Deng, Chao; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.3/5.0 | Submit date:2024/01/02
Biomarker  Immunotherapy  Nfe2l2  Ngs  Nsclc